It is reported that the serum autoantibodies against GAGE7, MAGEA1, PGP9.5, CAGE and p53 could be used for lung cancer diagnosis, while autoantibodies to PGP9.5 particularly correlate with poor prognosis for lung cancer patients (135). This evidence concerns the gene MAGEA1 and lung carcinoma.